Nearly 4% of the world’s population is affected by one of more than 80 different autoimmune diseases. coMra therapy is a safe and effective supportive therapy for conditions such as Rheumatoid Arthritis, Multiple Sclerosis, Lupus and more.
Autoimmune diseases are the third most common cause of chronic illness in the United States and appear to strike women two to three times more than men.1 Prevalence in Sub-saharan Africa is unknown due to lack of research data.
A normal immune system protects the body from infection and disease and fights off ‘intruders’. An autoimmune reaction occurs when the immune system mistakenly recognises the body as an invader and attacks the organs, tissues and cells it’s meant to protect. Inflammation, pain, swelling and tissue damage are the common results. Exact causes are unknown, but triggers can include genetic malfunction, viral infection, environmental factors2 and gut health3.
The most common Autoimmune Disorders include:
Diabetes Type 1
Multiple Sclerosis (MS)
Rheumatoid Arthritis (RA)
Generally, there are two types of medication used to treat the symptoms of an autoimmune disorder: 1) Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, which can help manage pain and inflammation and, 2) immunosuppressive drugs, which reduce the body’s immune response. The latter are only used in severe cases due to their suppression of the immune system.4
As a safe, alternative method of treatment, coMra therapy, which combines low-level laser therapy with the healing radiances of colour, magnetism and (in the Delta) ultrasound is used to treat pain, inflammation and many other symptoms associated with autoimmune conditions. Furthermore, the treatment also addresses the underlying, systemic issues that may be contributing to the condition. An important point to note is that coMra therapy works by balancing the immune system, not activating it! Hence there is no concern with regards to exacerbating an already overactive immune system.
The two most common forms of arthritis are osteoarthritis (degenerative joint disease that mostly affects the fingers, knees, and hips) and rheumatoid arthritis (autoimmune joint inflammation that often affects the hands and feet). Osteoarthritis (OA) affects more than 3.8% of the population while rheumatoid arthritis (RA) affects about 0.24%. Both types have been successfully treated with photobiomodulation, otherwise known as Low-level Laser Therapy.5
“One of the most reproducible effects of PBM is an overall reduction in inflammation, which is particularly important for disorders of the joints, traumatic injuries, lung disorders, and in the brain.”6
In a research study conducted in 2000 on the effects of low-level laser therapy (or photobiomodulation), results indicated a reduction of pain by 70% as well as reduced duration of morning stiffness by 27,5 minutes and a notable increase in finger/thumb to palm flexibility.7
Comra Therapy for Rheumatoid Arthritis
coMra therapy has proven very effective in the treatment of a variety of autoimmune conditions and has five Autoimmune treatment protocols in the User Guide. These are often used in conjunction with the Universal Treatments such as Universal 3 (Blood) and 5 (Somatic Biostimulation Routine 2).
For chronic and long-term Rheumatoid Arthritis, coMra therapy treatment would consist of Autoimmune 1 (which is also used for Lupus, Lyme Disease and Chronic Fatigue) along with localised treatment of painful or inflamed areas, such as joints. If the Rheumatoid Arthritis is more recent and less severe, localised treatment along with Universal 3 (Blood) is usually sufficient.